Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Financing Activities (2016 - 2025)

Phibro Animal Health has reported Cash from Financing Activities over the past 13 years, most recently at -$19.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$19.0 million for Q4 2025, down 106.87% from a year ago — trailing twelve months through Dec 2025 was -$42.6 million (down 116.8% YoY), and the annual figure for FY2025 was $207.1 million, up 3160.49%.
  • Cash from Financing Activities for Q4 2025 was -$19.0 million at Phibro Animal Health, down from $16.3 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PAHC hit a ceiling of $276.3 million in Q4 2024 and a floor of -$32.2 million in Q1 2025.
  • Median Cash from Financing Activities over the past 5 years was $1.5 million (2023), compared with a mean of $11.7 million.
  • Peak annual rise in Cash from Financing Activities hit 1979.09% in 2024, while the deepest fall reached 2352.85% in 2024.
  • Phibro Animal Health's Cash from Financing Activities stood at -$14.6 million in 2021, then skyrocketed by 125.49% to $3.7 million in 2022, then plummeted by 495.72% to -$14.7 million in 2023, then soared by 1979.09% to $276.3 million in 2024, then crashed by 106.87% to -$19.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$19.0 million (Q4 2025), $16.3 million (Q3 2025), and -$7.8 million (Q2 2025) per Business Quant data.